Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding

PHASE3CompletedINTERVENTIONAL

Enrollment

280

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

January 31, 2010

Study Completion Date

September 30, 2011

Conditions

Heavy Menstrual Bleeding

Interventions

DRUG

Levosert-20

DRUG

Mirena

All Listed Sponsors

lead

Uteron Pharma S.A.

INDUSTRY

NCT01695902 - Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding | Biotech Hunter | Biotech Hunter